Issued Patents 2021
Showing 25 most recent of 29 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11198686 | Crystal form and salt form of pyridone compound and preparation method therefor | Lei Zhang, Bin Chen, Yangguang Zhao, Jian Li | 2021-12-14 |
| 11192886 | S1P1 agonist and application thereof | Lingyun WU, Peng Zhang, Jian Li | 2021-12-07 |
| 11174270 | Crystal form of 3,4-dihydrothieno[3,2-d]pyrimidine compound and preparation method thereof | Jian Xiong, Jingjing Wang, Boyu HU, Haizhong TAN, Kevin X. Chen +1 more | 2021-11-16 |
| 11161817 | Quinoline derivative and use thereof as tyrosine kinase inhibitor | Yang Zhang, Zhengxia Chen, Meibi Dai, Wenju Li, Jian Li | 2021-11-02 |
| 11155559 | Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activity | Yuanshan Yao, Li Zhang, Zhaoguo Chen, Lele ZHAO, Lingyun WU | 2021-10-26 |
| 11155523 | Biphenyl compound as CCR2/CCR5 receptor antagonist | Yunfu Luo, Yuyong BA | 2021-10-26 |
| 11149055 | Crystal form of lanosterol prodrug compound and application thereof | Yizhi Liu, Yandong WANG, Xiaolin Li, Zhi Luo, Haiying He +1 more | 2021-10-19 |
| 11136315 | CXCR2 antagonist | Bin Chen, Xiawei WEI, Xuefeng Sun, Lei Zhang, Zhaoying Xu +5 more | 2021-10-05 |
| 11136319 | Anti-influenza virus pyrimidine derivative | Jian Xiong, Chaofeng Long, Jingjing Wang, Xiaoxin Chen, Kevin X. Chen +4 more | 2021-10-05 |
| 11130761 | Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitors | Yang Zhang, Yikai Wang, Linlin Chen, Tao Feng, Guoping HU +1 more | 2021-09-28 |
| 11124523 | 2,6-dioxaspiro [4,5] decane derivatives and preparation method therefor and pharmaceutical applications thereof | Yang Zhang, Wentao Wu, Guangwen Yang, Zhixiang Li, Jikui SUN +2 more | 2021-09-21 |
| 11117899 | [1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor | Kevin X. Chen, Yanxin YU, Xinde Chen, Li Zhang, Zhaoguo Chen +5 more | 2021-09-14 |
| 11091460 | Syk inhibitor and use method therefor | Shilan Liu, Guibai Liang, Hongjian Wang, Ming Zhang | 2021-08-17 |
| 11078194 | Salt form and crystal form serving as FGFR and VEGFR inhibitor compounds, and preparation method therefor | Zhengxia Chen, Yang Zhang, Meibi Dai, Hongfei Cheng, Suqin Yang +2 more | 2021-08-03 |
| 11053260 | Tri-cycle compound and applications thereof | Haiying He, Jing Wang, Zhigan Jiang, Yaxun YANG, Peng Shao +2 more | 2021-07-06 |
| 11046720 | Dimethylphosphine oxide compound | Lingyun WU, Xiawei WEI, Peng Zhang, Zhaoguo Chen, Cailin WANG +2 more | 2021-06-29 |
| 11040984 | Quinazoline compound for EGFR inhibition | Xile LIU, Charles Z. Ding, Lingyun WU, Lihong Hu, Haiwen Wan | 2021-06-22 |
| 11040968 | Pyridine derivative as ASK1 inhibitor and preparation method and use thereof | Chengde Wu, Tao Yu, Ning Li | 2021-06-22 |
| 11034681 | Crystal form of indole derivative and preparation method and use thereof | Yuanshan Yao, Bin Chen, Feng Gao, Yuan Chen, Ran Xu +3 more | 2021-06-15 |
| 11021445 | Carboxylic acid derivative as AT2R receptor antagonist | Yang Zhang, Wentao Wu, Zhixiang Li, Mingxing Teng, Guangwen Yang +2 more | 2021-06-01 |
| 11021486 | Coumarin-like cyclic compound as MEK inhibitor and use thereof | Qinghua Mao, Chengde Wu, Yong Huang, Zhen Gong, Jian Li | 2021-06-01 |
| 11014943 | Azetidine derivative | Jian Xiong, Cheng Xie, Kevin X. Chen, Xiongbin XU, Xuejin Zhang +6 more | 2021-05-25 |
| 11008292 | FGFR4 inhibitor and preparation method and use thereof | Zhengxia Chen, Chaofeng Long, Yang Zhang, Xiaoxin Chen, Yikai Wang +6 more | 2021-05-18 |
| 11001563 | SSAO inhibitor | Zhi Luo, Xiaolin Li, Yaxun YANG, Lele Yang, Peng Li +2 more | 2021-05-11 |
| 10995087 | Crystal form of URAT1 inhibitor, and preparation method therefor | Jianfei Wang, Yang Zhang, Wenyuan Zhu, Jian Li | 2021-05-04 |